I think MVF's track record speaks for itself as to vision/ambition. The Malaysian acquisition grew revenue by over 20%, and MVF has been looking for a Chinese partnership since the start of the year, so it is likely that we are close to breaking into the largest IVF market.
At a trailing P/E of just under 20 (about sector average), with above average earnings growth, what makes you think MVF is overvalued?
MVF Announcement, page-9
Add MVF (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.010(0.90%) |
Mkt cap ! $465.6M | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.15 | $1.11 | $836.8K | 747.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 10054 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 49259 | 5 |
View Market Depth
| Last trade - 14.19pm 19/11/2024 (20 minute delay) ? |
| MVF (ASX) Chart |
